Cargando…

Alkaline phosphatase treatment improves renal function in patients with severe sepsis or septic shock

Detalles Bibliográficos
Autores principales:	Heemskerk, S, Masereeuw, R, Moesker, O, Bouw, M, van der Hoeven, J, Peters, W, Velders, M, Russel, F, Pickkers, P
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2007
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4095068/ http://dx.doi.org/10.1186/cc5174

Ejemplares similares

Inflammation-induced renal injury subsides when endotoxin tolerance develops in humans as measured by urine proteomics
por: Draisma, A, et al.
Publicado: (2009)

Upregulation of renal inducible NO synthase and proximal tubule damage during human endotoxemia
por: Heemskerk, S, et al.
Publicado: (2004)

Pharmacokinetics, safety and tolerability of human recombinant alkaline phosphatase in healthy volunteers
por: Peters, E, et al.
Publicado: (2015)

New markers of inflammation-induced renal injury subside when endotoxin tolerance develops in humans as measured by urine proteomics
por: Heemskerk, S, et al.
Publicado: (2010)

Short-term beneficial effects of methylene blue on kidney damage in septic shock patients
por: Heemskerk, Suzanne, et al.
Publicado: (2007)

Predictors of mortality in renal transplant recipients with severe sepsis and septic shock
por: de Carvalho, Mônica Andrade, et al.
Publicado: (2013)

Innovative Drugs to Target Renal Inflammation in Sepsis: Alkaline Phosphatase
por: Hümmeke-Oppers, Femke, et al.
Publicado: (2019)

Urine biomarkers for gentamicin-induced acute kidney injury in the neonatal ICU
por: Jansen, D, et al.
Publicado: (2011)

Severe sepsis and septic shock in Croatian ICUs
por: Gornik, I, et al.
Publicado: (2006)

Lymphocyte phenotype during severe sepsis and septic shock
por: Le Dorze, M, et al.
Publicado: (2015)

Pro-atrial natriuretic peptide in patients with sepsis, severe sepsis and septic shock
por: Prucha, M, et al.
Publicado: (2005)

Alkaline phosphatase for treatment of sepsis-induced acute kidney injury: a prospective randomized double-blind placebo-controlled trial
por: Pickkers, Peter, et al.
Publicado: (2012)

Prognosis value of biomarkers in severe sepsis and septic shock
por: De La Torre-Prados, MV, et al.
Publicado: (2015)

The time course of adrenocortical hormones and cytokines in sepsis and/or septic shock
por: Dimopoulou, I, et al.
Publicado: (2005)

Effects of sepsis resuscitation bundle in cirrhotic patients with septic shock
por: Rinaldi, L, et al.
Publicado: (2010)

Experimental wound healing in severe sepsis and septic shock in humans
por: Koskela, M, et al.
Publicado: (2008)

Microcirculation and intravascular coagulopathy in patients with severe sepsis and septic shock
por: Wimmer, R, et al.
Publicado: (2010)

Lactate quartile concentration and prognosis in severe sepsis and septic shock
por: De La Torre-Prados, M, et al.
Publicado: (2014)

Fibrinogen at admission is an independent predictor of mortality in severe sepsis and septic shock
por: Azfar, M, et al.
Publicado: (2014)

Sepsis Brazil – early results: albumin and mortality rate in septic shock
por: David, C, et al.
Publicado: (2005)

Low dose immunoglobulin g for treatment of severe sepsis and septic shock
por: Iizuka, Y, et al.
Publicado: (2015)

Different hemoglobin thresholds for transfusion in patients with severe sepsis and septic shock
por: Kamio, T, et al.
Publicado: (2015)

Timing of the initiation of continuous renal replacement therapy and clinical outcome in patients with severe sepsis and septic shock
por: Cho, S
Publicado: (2012)

Hemodynamic monitoring in severe sepsis and septic shock in German ICUs
por: Jaschinski, U, et al.
Publicado: (2006)

Standard operating procedure in patients with severe sepsis and septic shock
por: Schwab, T, et al.
Publicado: (2009)

Prognosis scores on septic shock and severe sepsis in older people
por: Machado, RL, et al.
Publicado: (2009)

Factors related to the mortality of patients with severe sepsis and septic shock
por: Machado, RL, et al.
Publicado: (2009)

Procalcitonin as a prognostic biomarker of severe sepsis and septic shock
por: de Azevedo, JRA, et al.
Publicado: (2013)

Sustained prognostic value of proadrenomedulin in severe sepsis and septic shock
por: Cicuendez, R, et al.
Publicado: (2015)

The Neutrophil Function in Severe Sepsis/Septic Shock Patients With Mods
por: Klinngam, N, et al.
Publicado: (2015)

Underweight is associated with mortality in patients with severe sepsis and septic shock
por: Lee, SM, et al.
Publicado: (2015)

Sublingual leukocyte activation in patients with severe sepsis or septic shock
por: Fabian-Jessing, BK, et al.
Publicado: (2015)

Frequency and clinical spectrum of myocardial dysfunction in severe sepsis and septic shock
por: Pulido, JN, et al.
Publicado: (2010)

Survey of severe sepsis and septic shock management in Thailand: THAI-SHOCK SURVEY 2013
por: Chittawatanarat, K, et al.
Publicado: (2014)

Early goal directed therapy for sepsis and septic shock: collaborative implementation models
por: Baram, M, et al.
Publicado: (2004)

Clinical practice of fluid resuscitation in severe sepsis and septic shock on German ICUs
por: Ragaller, M, et al.
Publicado: (2006)

Best prediction for need of dialysis following cardiac surgery is obtained with the Thakar model
por: Kiers, HD, et al.
Publicado: (2011)

Clinical experience with lipopolysaccharide adsorber in cancer patients with severe sepsis and septic shock
por: Gromova, E, et al.
Publicado: (2010)

The association of early lactate clearance with inflammatory biomarkers in severe sepsis and septic shock
por: Otero, R, et al.
Publicado: (2006)

Peri-mortem and ante-mortem haemodynamic profile of severe sepsis/septic shock
por: Marcelino, P, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_dvq9r9djd0g34sqj06oa6pc7mh